Gschwendt M et al. |
The immunosuppressant FK-506, like cyclosporins and didemnin B, inhibits calmodulin-dependent phosphorylation of the elongation factor 2 in vitro and biological effects of the phorbol ester TPA on mouse skin in vivo. |
1989 |
Immunobiology |
pmid:2471685
|
Fujii Y et al. |
Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes. |
1989 |
Transplantation |
pmid:2472025
|
Tocci MJ et al. |
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. |
1989 |
J. Immunol. |
pmid:2472451
|
Beck Y and Akiyama N |
Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro. |
1989 |
Transplant. Proc. |
pmid:2472695
|
Stephen M et al. |
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. |
1989 |
Transplantation |
pmid:2463701
|
Inamura N et al. |
Immunosuppressive effect of FK506 on collagen-induced arthritis in rats. |
1988 |
Clin. Immunol. Immunopathol. |
pmid:2446810
|
Inamura N et al. |
Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. |
1988 |
Transplantation |
pmid:2447690
|
Ochiai T et al. |
Studies on FK506 in experimental organ transplantation. |
1988 |
Transplant. Proc. |
pmid:2450414
|
|
Immunosuppression: FK506. |
1988 |
Transplant. Proc. |
pmid:2450415
|
Todo S et al. |
Effect of FK506 in experimental organ transplantation. |
1988 |
Transplant. Proc. |
pmid:2450416
|